Clinical Trial Update: IMAGE: A Comparison of AlloMap Molecular Testing and Traditional Biopsy-based Surveillance for Heart Transplant Rejection [NA]

View source ↗

Summary

Completed clinical trial comparing AlloMap molecular testing with traditional biopsy-based surveillance for detecting heart transplant rejection.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiac Allograft Rejection
• Heart Diseases

Snippet

Sponsor: XDx | Conditions: Graft Rejection, Heart Diseases | NA | Status: COMPLETED